Insiders / Henderson Michael Thomas / Activity
Activity — Henderson Michael Thomas
14 moves.
| Date | Action | Company | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|
| Feb 11, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $723.7K | -11K -0.96% | 1,181,493 1.56% of shares | medium |
| Jan 14, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $676.6K | -8K -0.70% | 1,203,071 1.59% of shares | medium |
| Mar 11, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $621.3K | -8K -0.71% | 1,164,624 1.54% of shares | medium |
| Mar 11, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $615.0K | -8K -0.71% | 1,156,405 1.53% of shares | medium |
| Feb 11, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $481.2K | -8K -0.64% | 1,173,942 1.55% of shares | medium |
| Jan 14, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $447.9K | -5K -0.45% | 1,193,457 1.58% of shares | medium |
| Mar 11, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $259.3K | -3K -0.30% | 1,152,987 1.52% of shares | medium |
| Jan 14, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $192.3K | -2K -0.20% | 1,200,697 1.59% of shares | medium |
| Jan 14, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $152.8K | -2K -0.15% | 1,198,843 1.58% of shares | medium |
| Jan 14, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $113.2K | -1K -0.12% | 1,211,547 1.60% of shares | medium |
| Feb 11, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $62.1K | -955 -0.08% | 1,172,987 1.55% of shares | low |
| Jan 14, 2026 | Sell | APGE Apogee Therapeutics, Inc. Common Stock | $39.4K | -470 -0.04% | 1,192,987 1.58% of shares | low |
| Jan 21, 2026 | Other | SYRE Spyre Therapeutics, Inc. Common Stock | $0 | +63K +60.00% | 168,606 0.19% of shares | low |
| Jan 2, 2026 | Grant | APGE Apogee Therapeutics, Inc. Stock Option (Right to Buy) | — | +253K | 253,016 0.33% of shares | low |